How important is patient-centricity in rare disease studies?
September 6, 2017
Patient-centricity is becoming increasingly important in all areas, but particularly in rare diseases. In this post, Dr. Richard Scheyer discusses the importance of patient-centricity in rare disease studies.
How to Leverage Research Networks to Accelerate Orphan Drug Development
August 7, 2017
In this post, Dr. Terence Eagleton highlights the growing interest in the development of products in the rare disease space, the unique challenges involved, and strategies for leveraging rare disease research networks to accelerate drug development.
Important Cookie Information – This message will only appear once.